Yes, FtM hysterectomy surgery can affect the breast cancer risk. A hysterectomy removes the uterus, which is where the ovaries are attached. When the ovaries are removed, the body produces less estrogen, which is a hormone that can increase the risk of breast cancer.

A study published in the journal Breast Cancer Research and Treatment in 2014 found that women who had a hysterectomy with bilateral oophorectomy (removal of both ovaries) had a lower risk of breast cancer than women who had a hysterectomy alone. The study also found that the risk of breast cancer continued to decrease for up to 10 years after the surgery.

However, it’s important to note that there are other factors that can affect the risk of breast cancer, such as family history, age, and race. If you are transgender and are considering FtM hysterectomy surgery, it’s important to talk to your doctor about your individual risk factors for breast cancer.

Here are some additional things to keep in mind:

• The type of hysterectomy you have can also affect your risk of breast cancer. A total hysterectomy, which removes the uterus, cervix, and ovaries, has a greater impact on your risk than a partial hysterectomy, which only removes the uterus.
• If you have a hysterectomy after the age of 50, you may not see a significant decrease in your risk of breast cancer. This is because the ovaries typically stop producing estrogen around the age of 50, regardless of whether they are removed or not.
• If you have a family history of breast cancer, you may be at an increased risk of developing the disease. Talk to your doctor about your family history and how it may affect your risk.

Overall, FtM hysterectomy surgery can have a positive impact on your risk of breast cancer. However, it’s important to talk to your doctor about your individual risk factors and how the surgery may affect you.

FtM (Female to Male) hysterectomy surgery, which involves the removal of the uterus and potentially the cervix, does not directly affect breast tissue or breast cancer risk.

Breast cancer risk is influenced by various factors, including genetics, family history, hormonal factors, and lifestyle choices. Hysterectomy surgery alone does not have a direct impact on these factors.

However, it’s important to note that breast cancer risk is also influenced by hormonal factors, such as the use of hormone replacement therapy (HRT) or testosterone treatment in the context of gender transition. Testosterone, which is commonly used in masculinizing HRT for individuals transitioning from female to male, can potentially impact breast tissue.

The effects of testosterone on breast tissue are complex and not yet fully understood. Testosterone therapy may lead to changes in breast tissue, including a reduction in breast size and density. These changes may impact the risk assessment and screening strategies for breast cancer.

It is recommended to discuss your individual breast cancer risk and appropriate screening strategies with your healthcare provider. Factors such as personal and family history of breast cancer, age, and duration of testosterone therapy will be considered in assessing your risk profile.

Regular breast cancer screening, including clinical breast exams and mammograms, may still be recommended depending on individual risk factors, even after FtM hysterectomy surgery. It’s important to have open and ongoing discussions with your healthcare provider about breast health, breast cancer risk, and appropriate screening strategies tailored to your individual needs.

In summary, FtM hysterectomy surgery itself does not directly affect breast cancer risk, but individual breast cancer risk assessment and screening strategies may need to be adjusted based on factors such as hormone therapy and individual risk factors. Regular communication with your healthcare provider is essential for personalized breast health management.